Patents by Inventor Sara Biagiotti

Sara Biagiotti has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of evaluating the response of ataxia telangiectasia patients to glucocorticoids treatment
    Patent number: 10619208
    Abstract: The present invention relates to a novel procedure for evaluating the response of patients affected by Ataxia Talangiectasia (A-T) to glucocorticoids treatment. In particular, the procedure provides a step of qualitative and/or quantitative identification in the blood of said patients of the expression of a mRNA variant of the ATM (Ataxia-Talangiectasia-Mutated) gene produced by non-canonical splicing induced by glucocorticoid (GC). In fact, it was demonstrated that mRNA variant expression is present in the blood of patients who responded positively to treatment with GC.
    Type: Grant
    Filed: January 19, 2016
    Date of Patent: April 14, 2020
    Assignee: EryDel S.p.A.
    Inventors: Mauro Magnani, Sara Biagiotti, Michele Menotta
  • METHOD OF EVALUATING THE RESPONSE OF ATAXIA TELANGIECTASIA PATIENTS TO GLUCOCORTICOIDS TREATMENT
    Publication number: 20180016637
    Abstract: The present invention relates to a novel procedure for evaluating the response of patients affected by Ataxia Talangiectasia (A-T) to glucocorticoids treatment. In particular, the procedure provides a step of qualitative and/or quantitative identification in the blood of said patients of the expression of a mRNA variant of the ATM (Ataxia-Talangiectasia-Mutated) gene produced by non-canonical splicing induced by glucocorticoid (GC). In fact, it was demonstrated that mRNA variant expression is present in the blood of patients who responded positively to treatment with GC.
    Type: Application
    Filed: January 19, 2016
    Publication date: January 18, 2018
    Inventors: Mauro MAGNANI, Sara BIAGIOTTI, Michele MENOTTA
  • Drug delivery system
    Patent number: 8734787
    Abstract: Red blood cells can be used as effective drug delivery systems when they contain proteins that do not readily diffuse out and which form affinity complexes with the desired drug.
    Type: Grant
    Filed: June 7, 2010
    Date of Patent: May 27, 2014
    Assignee: Erydel S.p.A.
    Inventors: Mauro Magnani, Luigia Rossi, Sara Biagiotti, Marzia Bianchi
  • Drug Delivery System
    Publication number: 20120141540
    Abstract: Red blood cells can be used as effective drug delivery systems when they contain proteins that do not readily diffuse out and which form affinity complexes with the desired drug.
    Type: Application
    Filed: June 7, 2010
    Publication date: June 7, 2012
    Inventors: Mauro Magnani, Luigia Rossi, Sara Biagiotti, Marzia Bianchi